Page 820 - Cote clinical veterinary advisor dogs and cats 4th
P. 820

Glaucoma   389


             ○   Topical carbonic anhydrase inhibitors   ○   Enucleation or evisceration and implant   •  Clinical management of glaucoma is often
               (CAIs) (topical 2% dorzolamide or 1%   surgeries should be followed with histo-  difficult, and referral of these cases to a
  VetBooks.ir  ○   Topical dorzolamide/timolol combination   help determine cause of glaucoma (i.e.,   •  Medical therapy of glaucoma is expensive   Diseases and   Disorders
                                                                                    veterinary ophthalmologist is advised.
               brinzolamide q 8h, decreases pressure
                                                  pathologic exam of the removed tissue to
               about 5-7 mm Hg)
                                                                                    and is often required long term.
                                                  primary vs. secondary) and prognosis for
               (q 12h) can be administered rather than
               the individual products.           fellow eye.                     •  Buphthalmos  indicates  chronic  glaucoma,
                                                                                    whereas acute glaucoma, with its potentially
           •  Mannitol  1-2 g/kg  IV  over  20  minutes   Drug Interactions         better prognosis for vision, manifests with
             (usually greatly decreases pressure) to   •  Topical beta-adrenergic blockers may lower   episcleral injection and almost never with
             rapidly  lower  IOP  (first  effects  in  1-2   heart rate and blood pressure and may cause   buphthalmos.
             hours; maximum effect in 4-6 hours; dura-  bronchoconstriction in small-breed dogs and   •  Treatment (e.g., evisceration and implant,
             tion ≈8-10 hours) when there is a chance   in cats.                    enucleation) is generally indicated for per-
             for return of vision (e.g., acute primary    •  Systemic CAIs in dogs and cats are rarely used   manently blind, persistently glaucomatous
             glaucoma)                          since the advent of topical CAIs because they   eyes to remove the source of chronic intense
           •  Topical prostaglandins (PGF analogs, 0.005%   may cause metabolic acidosis and electrolyte   pain.
             latanoprost, 0.03% bimatoprost, or 0.004%   imbalances, as evidenced by depression   •  Digital pressure (pressing on the eyes through
             travoprost q 8-24h), usually greatly decrease   (perhaps related to hypokalemia), and in   closed eyelids) cannot be used to accurately
             pressure: used for primary glaucoma in dogs;   dogs, vomiting and diarrhea that require   assess IOP.
             not as effective in the feline glaucomas) may   drug  cessation.  Topical  CAI  preparations
             be used in the emergent case to promptly   are rarely associated with these side effects.  Prevention
             lower IOP; however, they should not be used   •  Topical  prostaglandins  often  cause  con-  The benefits of periodic tonometry in breeds
             in cases of lens luxation or instability or be   junctival hyperemia within minutes after   and/or eyes at risk are unknown but should be
             used with caution when there is significant   instillation that gradually declines over an   considered. Anterior uveitis that is unrecognized
             uveitis.                           hour or so and miosis that persists with the   or inadequately treated and controlled predis-
           •  Topical q 6h corticosteroids (prednisolone   IOP reduction.         poses an eye to secondary glaucoma. Cataractous
             1% or dexamethasone 0.1%) are indicated   •  Mannitol,  an  osmotic  diuretic,  should  be   eyes should be examined regularly for evidence
             if anterior uveitis is also present with no   avoided in patients with heart disease (risk of   of lens-induced uveitis, and treatment should
             corneal ulceration.                fluid overload/iatrogenic pulmonary edema).  be initiated when signs appear to prevent or
                                                                                  delay glaucoma.
           Chronic Treatment                   Possible Complications
           Medical:                            With poor or inadequate control of IOP, any   Technician Tips
           •  Topical carbonic anhydrase inhibitors (2%   or all of the following may occur:  •  Veterinary  nurses  and  technicians  should
             dorzolamide or 1% brinzolamide q 8h)  •  Buphthalmos  (p.  705)  causing  increased   encourage clients to bring their pets in for
           •  Topical beta-adrenergic antagonists or block-  corneal exposure  ± recurrent corneal   evaluation promptly to rule out glaucoma if
             ers (0.5% timolol or 0.5% betaxolol, usually   ulceration/corneal vascularization/corneal   they complain of a bloodshot eye or acute
             q 8-12h)                           pigmentation                        visual disturbance.
           •  Topical prostaglandins (PGF analogs, 0.005%   •  Lens luxation/subluxation  •  Restraint for animals undergoing tonometry
             latanoprost, 0.03% bimatoprost, or 0.004%   •  Optic nerve and retinal degeneration  is important. Care should be taken to avoid
             travoprost q 12-24h): used  for primary   •  Ocular, head pain         placing any pressure on the jugular veins or
             glaucoma in dogs; not as effective in feline   •  Blindness            eyelids because excessive pressure in these
             glaucomas                                                              areas may result in falsely elevated IOP
           •  ±  Topical and/or systemic corticosteroids   Recommended Monitoring   measurements. Excessive struggling should
             (prednisolone) (when anterior uveitis also   •  Regular exams with tonometry (e.g., monthly   be avoided as well because this may alter
             present; taper to lowest effective dose)  after IOP control initially achieved) are nec-  IOP readings.
           •  In all of the breed-related primary glaucomas,   essary to monitor IOP (should be maintained
             the disease continues to progress (even   at < 15 mm Hg) and maintain vision for as   Client Education
             though IOP may be controlled), and often,   long as possible.        •  Glaucoma is a chronic disease that requires
             combinations of several topical IOP-lowering   •  As  the  glaucoma  progresses,  increased   regular and diligent therapy. Missed medica-
             drugs or surgery (see below) are eventually     frequency and/or additional topical drugs   tion results in inadequate control of IOP,
             necessary.                         to lower IOP are usually necessary.  loss of sight, and pain.
           Surgical:                                                              •  Primary glaucoma occurs in more than 20
           •  Anterior  chamber  shunts  and  laser  cyclo-   PROGNOSIS & OUTCOME   dog breeds.
             photocoagulation are procedures offered by                           •  Dogs  with  cataracts  that  are  not  surgical
             most veterinary ophthalmologists to prolong   •  Prognosis  is  usually  poor  for  the  first  eye   candidates require periodic eye exams and
             vision and prevent ocular pain. Laser cyclo-  presented with primary glaucoma in dogs   tonometry indefinitely because they are at
             photocoagulation may be performed with a   because the disease is often advanced and   increased risk for developing glaucoma.
             transscleral approach or with the assistance   refractory to medical therapy.
             of a microendoscope.              •  Prognosis  for  the  fellow  eye  is  better,  and   SUGGESTED READING
           •  Removal  of  the  lens  (referable  procedure;   prophylactic therapy with a beta-adrenergic   Plummer CE, et al: The canine glaucomas. In Gelatt
             glaucoma secondary to lens luxation) should   blocker or prostaglandin can significantly delay   KN, editor: Veterinary ophthalmology, ed 5, Ames,
             be performed as soon as possible in cases of   the onset of glaucoma for up to 30 months.  IA, 2013, Wiley-Blackwell, pp 900-1142.
             anterior lens displacement/luxation.
           •  End-stage  blind  and  buphthalmic  glauco-   PEARLS & CONSIDERATIONS  AUTHOR: Caryn E. Plummer, DVM, DACVO
                                                                                  EDITOR: Diane V. H. Hendrix, DVM, DACVO
             matous globes may be treated by
             ○   Enucleation                   Comments
             ○   Evisceration and intrascleral prosthesis  •  Patients with dilated pupils, corneal edema,
             ○   Intravitreal gentamicin or cidofovir injec-  and conjunctival hyperemia require tonom-
               tion (dogs)                      etry to estimate IOP.

                                                      www.ExpertConsult.com
   815   816   817   818   819   820   821   822   823   824   825